Mumbai (Maharashtra) [India], Aug 3 (ANI): Pharmaceutical and biotechnology major Wockhardt said on Monday it has entered into an agreement with the UK Government to fill-finish Covid-19 vaccines.
Mumbai (Maharashtra) [India], July 31 (ANI): Equity benchmark indices closed marginally lower on Friday in line with Asian peers following a record contraction in economic data from the United States.
Mumbai (Maharashtra) [India], July 31 (ANI): Equity benchmark indices wobbled between gains and losses during early hours on Friday in line with Asian peers following a record contraction in economic data from the United States.
Mumbai (Maharashtra) [India], July 30 (ANI/BusinessWire India): In a move to expand access and empower Indian patients to take charge of their health, Abbott and leading online pharmacy and healthcare platform, 1mg today announced their collaboration to make Abbott's continuous glucose monit
Mumbai (Maharashtra) [India], July 30 (ANI): Equity benchmark indices swung nearly 1 per cent lower during the afternoon session on Thursday ahead of the expiry day of monthly futures and options contracts.
Mumbai (Maharashtra) [India], July 30 (ANI): Equity benchmark indices edged higher during early hours on Thursday ahead of the expiry day of monthly futures and options contracts.
Mumbai (Maharashtra) [India], July 28 (ANI): India Ratings and Research (Ind-Ra) has said that Indian active pharmaceutical ingredient (API) companies will benefit from improving demand outlook in the United States.
New Delhi [India], July 28 (ANI): Union Minister for Chemicals and Fertilizers Sadananda Gowda on Monday said that India has proved that it is the "pharmacy of the world" in the ongoing COVID-19 pandemic.
Mumbai (Maharashtra) [India], July 27 (ANI): Equity benchmark indices slipped during early hours on Monday mainly due to losses witnessed in pharma and banking stocks.
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Mumbai (Maharashtra) [India], July 24 (ANI): Sun Pharmaceutical Industries said on Friday its US-based subsidiary Taro Pharmaceutical Inc has resolved all cases in connection with multi-year investigations by the Department of Justice's (DoJ's) Anti-trust Division and Civil Division into the